Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Biology & Therapy|August 13, 2002
Phase I study of perillyl alcohol in patients with refractory malignanciesJohn R Murren, Giuseppe Pizzorno, Susan A DiStasio, et al.
International Journal of Molecular Medicine|June 18, 2004
Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarrayYvonne Collins, Dong Feng Tan, Tanja Pejovic, et al.
Journal of Ovarian Research|December 1, 2023
Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cellsYi Zhang, Roslyn Tedja, Michael Millman, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cellsYi Zhang, Roslyn Tedja, Michael Millman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2008
Diagnostic markers for early detection of ovarian cancerIrene Visintin, Ziding Feng, Gary Longton, et al.
Cancer Medicine|January 10, 2014
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatmentVinicius Craveiro, Yang Yang-Hartwich, Jennie C Holmberg, et al.
Frontiers in Immunology|July 12, 2023
Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancerNicholas Adzibolosu, Ayesha B Alvero, Rouba Ali-Fehmi, et al.
Gynecologic Oncology|August 12, 2015
Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivoCarlton L Schwab, Diana P English, Jonathan Black, et al.
Cancer Research|July 22, 2010
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer riskElena Ratner, Lingeng Lu, Marta Boeke, et al.
Pageof 6